Being a multidrug-resistant and an invasive pathogen, Acinetobacter baumannii is one of
the major causes of nosocomial infections in the current healthcare system. It has been …

Colistin regained global interest as a consequence of the rising prevalence of multidrug-
resistant Gram-negative Enterobacteriaceae. In parallel, colistin-resistant bacteria emerged …

Increasing antibiotic resistance in multidrug-resistant (MDR) Gram-negative bacteria (MDR-
GNB) presents significant health problems worldwide, since the vital available and effective …

Following their initial discovery in the 1940s, polymyxin antibiotics fell into disfavor due to
their potential clinical toxicity, especially nephrotoxicity. However, the dry antibiotic …

Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

INTRODUCTION: The increased use of colistin against infections caused by Acinetobacter
baumannii and Pseudomonas aeruginosa has resulted in colistin resistance. The purpose of …

The objective of this review is to collect and present the results of relevant studies on an
international level, on the subject of colistin resistance due to mcr genes prevalence in …

Objectives To identify the molecular mechanism of colistin resistance in an MDR
Acinetobacter baumannii clinical strain isolated in 2008 from a meningitis case in Brazil …

Antibiotic resistance is a growing global concern in the field of medicine as it renders
bacterial infections difficult to treat and often more severe. Acinetobacter baumannii is a …

Skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA) require the
development of new and effective topical antibiotics. In this context, melittin, the main …